Truist Financial Increases Aflac (NYSE:AFL) Price Target to $82.00

Aflac (NYSE:AFL) had its price objective boosted by research analysts at Truist Financial from $80.00 to $82.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has a “hold” rating on the financial services provider’s stock. Truist Financial’s price target would indicate a potential downside of 1.45% from the stock’s previous close.

AFL has been the topic of a number of other reports. Raymond James increased their price target on Aflac from $83.00 to $88.00 and gave the stock an “outperform” rating in a research report on Friday, February 2nd. The Goldman Sachs Group raised their target price on Aflac from $61.00 to $75.00 and gave the company a “sell” rating in a research note on Tuesday, January 9th. Wells Fargo & Company lowered their price target on shares of Aflac from $83.00 to $81.00 and set an “equal weight” rating for the company in a research report on Thursday, April 11th. Evercore ISI downgraded shares of Aflac from an “in-line” rating to an “underperform” rating and lifted their price objective for the company from $76.00 to $78.00 in a research report on Thursday, January 4th. Finally, Keefe, Bruyette & Woods upped their target price on shares of Aflac from $83.00 to $87.00 and gave the stock a “market perform” rating in a research report on Wednesday, April 10th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $82.31.

Aflac Stock Performance

Shares of AFL opened at $83.21 on Friday. The stock has a market capitalization of $47.88 billion, a PE ratio of 9.18, a price-to-earnings-growth ratio of 2.31 and a beta of 0.91. The business’s fifty day moving average price is $83.14 and its 200 day moving average price is $81.89. The company has a debt-to-equity ratio of 0.34, a current ratio of 0.08 and a quick ratio of 0.06. Aflac has a 12-month low of $64.10 and a 12-month high of $86.26.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Wednesday, May 1st. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.58 by $0.08. Aflac had a net margin of 27.67% and a return on equity of 16.88%. The company had revenue of $5.44 billion for the quarter, compared to the consensus estimate of $4.09 billion. During the same period last year, the firm posted $1.55 EPS. The company’s revenue for the quarter was up 13.3% on a year-over-year basis. Equities research analysts forecast that Aflac will post 6.41 EPS for the current year.

Insider Activity at Aflac

In other news, Director Arthur Reginald Collins sold 3,000 shares of the firm’s stock in a transaction dated Thursday, February 22nd. The shares were sold at an average price of $79.73, for a total transaction of $239,190.00. Following the completion of the transaction, the director now owns 5,592 shares in the company, valued at approximately $445,850.16. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, Director Arthur Reginald Collins sold 3,000 shares of the stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $79.73, for a total transaction of $239,190.00. Following the completion of the sale, the director now owns 5,592 shares in the company, valued at approximately $445,850.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Masatoshi Koide sold 30,493 shares of Aflac stock in a transaction on Friday, February 16th. The stock was sold at an average price of $79.91, for a total value of $2,436,695.63. Following the completion of the transaction, the director now owns 86,090 shares in the company, valued at $6,879,451.90. The disclosure for this sale can be found here. Insiders sold 46,493 shares of company stock valued at $3,765,706 over the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

Institutional Trading of Aflac

Hedge funds have recently bought and sold shares of the company. Signaturefd LLC boosted its stake in Aflac by 1.1% in the 1st quarter. Signaturefd LLC now owns 52,511 shares of the financial services provider’s stock worth $4,509,000 after purchasing an additional 568 shares during the period. Catalina Capital Group LLC boosted its position in shares of Aflac by 58.4% in the first quarter. Catalina Capital Group LLC now owns 4,027 shares of the financial services provider’s stock worth $346,000 after buying an additional 1,484 shares during the period. Avidian Wealth Solutions LLC grew its holdings in shares of Aflac by 3.5% during the first quarter. Avidian Wealth Solutions LLC now owns 6,587 shares of the financial services provider’s stock valued at $566,000 after buying an additional 221 shares in the last quarter. Southern Capital Advisors LLC raised its position in Aflac by 1.3% during the first quarter. Southern Capital Advisors LLC now owns 17,216 shares of the financial services provider’s stock valued at $1,478,000 after buying an additional 221 shares during the period. Finally, TFB Advisors LLC lifted its stake in Aflac by 131.5% in the 1st quarter. TFB Advisors LLC now owns 10,477 shares of the financial services provider’s stock worth $886,000 after acquiring an additional 5,952 shares in the last quarter. 67.44% of the stock is owned by hedge funds and other institutional investors.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.